Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men

Diabetes Research and Clinical Practice

Volumn 87, Issue 3, 2010, Pages 379-384

  Petersson, Helena ^a   Ärnlöv, Johan ^a,b   Zethelius, Björn ^a   Risérus, Ulf ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b Högskolan Dalarna ^*  (Sweden)

Author keywords

Fatty acid composition; Lipogenesis; Liver fat; Stearoyl coenzymeA desaturase 1

Indexed keywords

ACYL COENZYME A DESATURASE; ADIPONECTIN; ALANINE AMINOTRANSFERASE; CHOLESTEROL ESTER; DIHOMO GAMMA LINOLENIC ACID; LINOLEIC ACID; LINOLEOYL COENZYME A DESATURASE; OLEIC ACID; PALMITOLEIC ACID;

ABDOMINAL OBESITY; AGED; ARTICLE; CONTROLLED STUDY; FAT INTAKE; FATTY LIVER; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID METABOLISM; MALE; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; AGING; BODY MASS INDEX; DIETARY FATS; FATTY ACIDS; FATTY LIVER; FLUOROIMMUNOASSAY; HUMANS; INSULIN RESISTANCE; LIFE STYLE; MALE; OBESITY, ABDOMINAL; REGRESSION ANALYSIS; STEAROYL-COA DESATURASE; SWEDEN;

EID: 77649335848     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.11.019     Document Type: Article

References (28)

1. Kotronen A., and Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 27-38
2. Westerbacka J., Lammi K., Hakkinen A.M., Rissanen A., Salminen I., Aro A., et al. Dietary fat content modifies liver fat in overweight nondiabetic subjects. J. Clin. Endocrinol. Metab. 90 (2005) 2804-2809
3. Tiikkainen M., Bergholm R., Vehkavaara S., Rissanen A., Hakkinen A.M., Tamminen M., et al. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 52 (2003) 701-707
4. Sekiya M., Yahagi N., Matsuzaka T., Najima Y., Nakakuki M., Nagai R., et al. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 38 (2003) 1529-1539
5. Hodson L., Skeaff C.M., and Fielding B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 47 (2008) 348-380
6. de Almeida I.T., Cortez-Pinto H., Fidalgo G., Rodrigues D., and Camilo M.E. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin. Nutr. 21 (2002) 219-223
7. Nakamura M.T., and Nara T.Y. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu. Rev. Nutr. 24 (2004) 345-376
8. Chu K., Miyazaki M., Man W.C., and Ntambi J.M. Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation. Mol. Cell. Biol. 26 (2006) 6786-6798
9. Kotronen A., Seppanen-Laakso T., Westerbacka J., Kiviluoto T., Arola J., Ruskeepaa A.L., et al. Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes 58 (2009) 203-208
10. Hedstrand H. A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Ups. J. Med. Sci. Suppl. 19 (1975) 1-61
11. Skarfors E.T., Selinus K.I., and Lithell H.O. Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. BMJ 303 (1991) 755-760
12. Boberg M., Croon L.B., Gustafsson I.B., and Vessby B. Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. Clin. Sci. (Lond.) 68 (1985) 581-587
13. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237 (1979) E214-223
14. Byberg L., Zethelius B., McKeigue P.M., and Lithell H.O. Changes in physical activity are associated with changes in metabolic cardiovascular risk factors. Diabetologia 44 (2001) 2134-2139
15. Riserus U., and Ingelsson E. Alcohol intake, insulin resistance, and abdominal obesity in elderly men. Obesity (Silver Spring) 15 (2007) 1766-1773
16. Dobrzyn A., and Ntambi J.M. Stearoyl-CoA desaturase as a new drug target for obesity treatment. Obes. Rev. 6 (2005) 169-174
17. Araya J., Rodrigo R., Videla L.A., Thielemann L., Orellana M., Pettinelli P., et al. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin. Sci. (Lond.) 106 (2004) 635-643
18. Allard J.P., Aghdassi E., Mohammed S., Raman M., Avand G., Arendt B.M., et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study. J. Hepatol. 48 (2008) 300-307
19. Westerterp K.R., Smeets A., Lejeune M.P., Wouters-Adriaens M.P., and Westerterp-Plantenga M.S. Dietary fat oxidation as a function of body fat. Am. J. Clin. Nutr. 87 (2008) 132-135
20. Stefan N., Peter A., Cegan A., Staiger H., Machann J., Schick F., et al. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia 51 (2008) 648-656
21. Warensjo E., Riserus U., Gustafsson I.B., Mohsen R., Cederholm T., and Vessby B. Effects of saturated and unsaturated fatty acids on estimated desaturase activities during a controlled dietary intervention. Nutr. Metab. Cardiovasc. Dis. 18 (2008) 683-690
22. Chong M.F., Hodson L., Bickerton A.S., Roberts R., Neville M., Karpe F., et al. Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding. Am. J. Clin. Nutr. 87 (2008) 817-823
23. Petersson H., Basu S., Cederholm T., and Riserus U. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analyses in middle-aged men. Br. J. Nutr. 99 (2008) 1186-1189
24. Wang L., Folsom A.R., Zheng Z.J., Pankow J.S., and Eckfeldt J.H. Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Clin. Nutr. 78 (2003) 91-98
25. Riserus U., Willett W.C., and Hu F.B. Dietary fats and prevention of type 2 diabetes. Prog. Lipid Res. 48 (2009) 44-51
26. Desvergne B., Michalik L., and Wahli W. Transcriptional regulation of metabolism. Physiol. Rev. 86 (2006) 465-514
27. Attie A.D., Krauss R.M., Gray-Keller M.P., Brownlie A., Miyazaki M., Kastelein J.J., et al. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J. Lipid Res. 43 (2002) 1899-1907
28. Liu G., Lynch J.K., Freeman J., Liu B., Xin Z., Zhao H., et al. Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors. J. Med. Chem. 50 (2007) 3086-3100